Ingrid Baar

Ingrid Baar

Auto-generated profile, based on publicly available information

Ingrid Baar

Intense Care Unit, Antwerp University Hospital, Antwerp, Belgium, uza.be

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2021 in Case Reports in Neurological Medicine
Verified
Journal Article
Open access
PDF file
JKJeroen Kerstens
Jeroen Kerstens
BDBusra Durmus
Busra Durmus
SLStijn Lambrecht
Stijn Lambrecht
IBIngrid Baar
Ingrid Baar
MIMargareta M. Ieven
Margareta M. Ieven
PJPhilippe G. Jorens
Philippe G. Jorens
Invasive infection with Lancefield group C streptococci in humans is extremely rare, with the vast majority of clinical isolates belonging to Streptococcus dysgalactiae subsp. equisimilis. We report a case of meningoencephalitis in a 69-year-old man caused by Streptococcus equi subsp. equi, a microbe that causes strangles in Equus caballus (i.e., the horse). This is only the fourth infection with this subtype of the central nervous system (CNS) reported in humans. The invasiveness of these bacteria, known to be capable of releasing strongly immunogenic exotoxins, is illustrated by white matter lesions that are present in the acute phase. This patient initially recovered well after treatment with antibiotics and glucocorticoids. However, the patient was readmitted 5 months later with multiple intraparenchymatous cerebral haemorrhages. Cerebral angiography confirmed the presence of a suspected superficial dural arteriovenous fistula (DAVF), which is seldom reported after CNS infection. The invasiveness of these bacteria was illustrated by white matter lesions present in the acute phase and the occurrence of a de novo dural arteriovenous fistula in the follow-up period.

1 January 2026 in Case Reports in Critical Care
Verified
Journal Article
Open access
PDF file
ANAndrea Nemethova
Andrea Nemethova
WRWillem De Ridder
Willem De Ridder
IBIngrid Baar
Ingrid Baar
AAAlicia Alonso-Jimenez
Alicia Alonso-Jimenez
Guillain‐Barré syndrome (GBS) is an acute autoimmune polyradiculoneuropathy typically characterized by an ascending sensorimotor deficit with potential involvement of bulbar and respiratory muscles that may necessitate intensive care admission and mechanical ventilation. Standard treatment includes supportive care, management of complications such as weakness, immobility, respiratory failure, autonomic dysfunction and pain, along with early initiation of immunotherapy—either intravenous immunoglobulin (IVIg) or plasma exchange (PE). However, lack of significant clinical improvement following immunotherapy should prompt consideration of alternative diagnoses, including pan‐neurofascin antibody‐positive autoimmune nodopathy (panNF + AN). In this report, we present two patients presenting with a severe GBS‐like neuropathy. Initial treatment with IVIg resulted in either no response or only transient, mild improvement, followed by rapid clinical deterioration to near‐complete tetraplegia, respiratory failure, and autonomic and cranial nerve involvement. Both patients were unresponsive to further treatment with a second course of IVIg, PE and corticosteroids. Subsequent diagnostic evaluation revealed the presence of pan‐neurofascin antibodies, confirming panNF + AN. This prompted initiation of treatment with rituximab, which resulted in sustained and complete clinical recovery in both cases. A transient or mild clinical response—or an initial lack of response—to standard GBS‐treatment followed by rapid and severe deterioration in cases initially presenting as GBS should be considered a red flag warranting evaluation for AN‐associated antibodies. Recognition of this important GBS mimic is critical, as it requires an alternative treatment approach with rituximab, which has been associated excellent clinical outcomes.

Verified
Closed access
VDV. Demaerel
V. Demaerel
IBIngrid Baar
Ingrid Baar
WVWalter Verbrugghe
Walter Verbrugghe
LVL. Verslegers
L. Verslegers
JHJef Huyskens
Jef Huyskens
PPPaul Maria R. Parizel
Paul Maria R. Parizel